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Health-related quality of life (HRQoL) is recommended as one of essential parameters to evaluate treatment effect and clinical
outcome in patients with Crohn’s disease (CD). Recent studies reported that psychological factors might play a role in HRQoL
in Western and American CD patients. Sufficient evidences in Chinese CD patients are still unavailable. This study is dedicated
to investigate the correlation of various psychological factors with HRQoL in Chinese CD patients. We prospectively collected 40
active and 40 quiescent CD patients in China and found that psychological factors, especially neuroticism and anxiety, significantly
correlate with and affect HRQoL in both active and quiescent CD groups. This is the first report revealing correlation between
psychological factors and HRQoL in Chinese CD patients. Therefore, we assume that our results can contribute to a better
understanding of etiology and tailoring ofmanagement in Chinese patients with Crohn’s disease and are beneficial to our colleagues
to compare the heterogeneous characteristics of Crohn’s disease in different ethnic groups.
1. Introduction
Crohn’s disease (CD) is characterized by chronic, transmu-
ral intestinal inflammation in which periods of remission
with variable length are interrupted by relapse episodes [1].
Health-related quality of life (HRQoL) has been broadly
defined as a concept that includes emotional, social, and
physical dimensions of health functioning [2]. Improvement
in quality of life in patients with CD has been increas-
ingly attracting attention of clinical physicians. Inflamma-
tory Bowel Disease Questionnaire (IBDQ) was therefore
developed and being widely used to comprehensively assess
healthy status and HRQoL in patients with inflammatory
bowel disease (IBD) [3, 4].On the basis of the assumption that
IBDQ could effectively reflect patient’s symptom load, psy-
chological fluctuation, and quality of life [4], IBDQ has also
been recommended as one of essential instruments to evalu-
ate treatment effect and clinical outcome [5].
In recent decades, a series of studies performed in Europe
and North America reported several distinct psychological
traits that relate toHRQoL and outcome of surgery in patients
with CD [2, 4, 6, 7]. These findings intensively suggest that
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some disease-unrelated variables may affect IBDQ score as
well and, consequently, it is necessary to consider these
variables into the evaluation ofHRQoL and figure out towhat
extent that these variables would influence clinical outcome
in patients with CD.
To our knowledge, there is no report investigating corre-
lation between psychological factors and HRQoL in Chinese
patients with CD. Considering the heterogeneous character-
istics of Crohn’s disease in different ethnic groups reported
before, we assumed that there is a necessity to perform an
investigation in Chinese population.Therefore, current study
was dedicated to analyze the correlation between various
psychological factors and HRQoL in patients with CD from
China. All questionnaires adopted in current study have been
validated for Chinese population.
2. Methods
2.1. Patients. Patients in current study were recruited from
outpatient clinic of CD in Jinling Hospital between March
2012 and August 2012. Patients were first screened by a
physician for eligibility assessment. Then, their blood sample
would be collected for C-reactive protein (CRP), erythrocyte
sedimentation rate (ESR), and whole blood analysis. After-
wards, they would be evaluated by another physician for dis-
ease activity using CDAI score. Subsequently, patients were
required to accomplish all questionnaires (self-reporting)
truthfully and independently, and then they were checked by
a clinical nurse.
All enrolled patients were 18–65 years old and diagnosed
as CD by clinical manifestations, radiologic, endoscopic, and
histopathologic evidences. The exclusion criteria included
current or previous mental disorders, receiving or used to
receive psychotherapy, presence of major medical conditions
or chronic disease history other than inflammatory bowel
disease, and unwilling to participate in or cannot accomplish
current study.
2.2. Health-Related Quality of Life and Psychological Evalua-
tion. IBDQ is the most widely used and validated disease-
specific instrument [3], which contains 32 items and assesses
four aspects (subscales) of health-related quality of life: emo-
tional function (12 items), social function (5 items), bowel
function (10 items), and systemic symptom (5 items) [8]. Each
item is scored with 7-level Likert scale; the higher score, the
better health-related quality of life [4]. This questionnaire
could provide a total score and four subscale scores of each
aspect. The IBDQ used in current study has been translated
and validated in Chinese population [9].
To assess neuroticism and social conformity and desir-
ability, the Neuroticism and Lie subscales from the Eysenck
Personality Inventory (EPI) were adopt in current study [10].
Twenty-three items are designed to evaluate neuroticism
(Neuroticism subscale) and the other 21 items are assigned for
social desirability (Lie subscale).The reliability and validity of
this scale are well established in Chinese population [11].
The Hospital Anxiety and Depression Scale (HADS) was
first developed in 1983 [12] and has been extensively used
in subsequent studies to identify the potential anxiety and
depression in nonpsychiatric hospitalized patients [13]. This
questionnaire includes separated Anxiety and Depression
subscaleswith seven items, respectively. Previous studies have
confirmed the validity of this scale among Chinese patients
[14, 15].
To determine the dynamics of aggression among individ-
uals, the Buss-Perry Aggregation (BPA) questionnaire was
employed in this study [16]. BPA has been one of the most
popular self-report inventories for the measurement of four
different dimensions (anger, hostility, physical aggression,
and verbal aggression) during the past two decades since its
publication in 1992 [17]. This 29-item questionnaire is scored
with a 5-level scale for each question, contributing to a total
score and four subscales of each dimension. A higher score
suggests a higher level of aggression feelings [4]. BPA has
been validated in Chinese version as well [17].
2.3. Statistical Consideration. All statistical tests were per-
formed with SPSS software (SPSS for Windows, version
13.0, SPSS, Chicago, IL). All analyses were 2-tailed and
differences were considered statistically significant when 𝑃
values <0.05. Continuous variables were described as mean ±
SD and compared with unpaired student’s 𝑡-test. Categorical
variables were presented as percentages and compared with
Fisher’s exact test or Chi-square test. Hierarchical multiple
regression was performed to analyze the effect of different
psychological factors on HRQoL independent of the influ-
ence of other parameters, such as disease activity (CDAI
score). In this model, dependent parameters were IBDQ
and its subscales; independent factors included demographic
parameters (including age, gender, years of education, and
duration of disease) entered in step 1, andCDAI score entered
in step 2 as a control parameter, and then all psychological
factors entered in step 3. Spearman correlation analysis was
performed to investigate the correlation between psycholog-
ical parameters and IBDQ and its subscales. Multiple linear
regression analysis with forward stepwise methods was used
to investigate to what extent that psychological factors could
affect IBDQ and its subscales. Psychological variables that
displayed a significant correlation with IBDQ or its subscales
were entered in the regression analysis.
2.4. Ethical Statement. This study was approved by theMedi-
cal Ethics Committee of Jinling Hospital. A written informed
consent was obtained from each enrolled patient.
3. Results
A total of 121 patients diagnosed with CD visited our clinics
during the period of study. According to the exclusion crit-
eria, 80 patients were eligible and finally enrolled (Figure 1).
To better investigate the correlation between psychologi-
cal factors andHRQoL in these patients, we firstly performed
a hierarchical multiple regression analysis to discover and
then exclude potential confounding parameters. According
to Table 1, demographics (step 1) did not contribute to
IBDQ or any of its subscales. However, when CDAI score
was entered into this model (step 2), 𝑅 square elevated
dramatically to a statistical significant degree, indicating that
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CD patients from out-patient clinic
(n = 121)
Eligibility assessment
(n = 80)
Blood sample collection
(CRP, ESR, PLT)
Disease activity evaluation
(CDAI score)
Quiescent CD group
(n = 40)
Active CD group
(n = 40)
Questionnaires accomplishment
Health-related quality of life
∙ Inflammatory bowel disease questionnaire
Psychological factors:
∙ Neuroticism and lie subscales of eysenck
personality inventory
∙ Hospital anxiety and depression scale
∙ Buss-perry aggregation questionnaire
Figure 1: Study design of current prospective study. A total of 121 patients with Crohn’s disease from outpatient clinic were recruited in
the current study. After eligibility assessment, 80 eligible patients were enrolled. Their blood samples were collected for CRP, ESR, and PLT
analysis. Afterwards, they were evaluated for disease activity with Crohn’s disease activity index (CDAI score) and then divided into quiescent
(CDAI ≤ 150 points) and active (CDAI > 150 points) CD groups. All enrolled patients were subsequently required to accomplish HRQoL-
related questionnaire (Inflammatory Bowel Disease Questionnaire, IBDQ) and psychological factor-related questionnaires, including
Neuroticism and Lie subscale from Eysenck Personality Inventory (EPI), Hospital Anxiety and Depression Scale (HADS), and Buss-Perry
Aggregation (BPA) questionnaire. CD: Crohn’s disease.
disease activity was a significant covariant in the relationship
between psychological factors and HRQoL. Notably, when
psychological factors were entered into this model (step 3),
the 𝑅 square increased again, demonstrating that a predictive
power was added to the model by the addition of psycholog-
ical factors (Table 1).
Therefore, to reduce the confounding effect of disease
activity in the relationship between psychological factors
and HRQoL [18–20], we established two independent groups
with different disease activity (active CD and quiescent CD),
measured by Crohn’s disease activity index (CDAI), and
analyzed them separately. Among them, 40 patients were
assigned into active CD group (CDAI ≤ 150 points) and the
other 40 participates were in quiescent CD group (CDAI >
150 points). Both of them displayed a male predominance,
which was in accordance to our previous investigations
[21]. The CDAI scores were 91.8 points and 247.8 points,
respectively, suggesting a distinct variance of disease activity
between the two groups (𝑃 < 0.001). Meanwhile, CRP (𝑃 <
0.001) and ESR (𝑃 = 0.022) levels increased significantly
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Table 1: Analysis of potential confounding parameters in the relationship between psychological factors andHRQoL in patients with Crohn’s
disease.
Step 1 (demographics∗) Step 2 (CDAI score) Step 3 (psychological factors&)
𝑅 square P value 𝑅 square P value 𝑅 square P value
IBDQ 0.060 0.195 0.470 <0.001 0.747 <0.001
IBDQ-E 0.081 0.090 0.376 <0.001 0.780 <0.001
IBDQ-SF 0.018 0.709 0.196 0.002 0.345 0.002
IBDQ-B 0.040 0.367 0.446 <0.001 0.656 <0.001
IBDQ-SS 0.052 0.252 0.531 <0.001 0.701 <0.001
∗Demographics included age, gender, years of education, and duration of disease; &psychological factors includedNeuroticism and Lie scores, Hospital anxiety
and depression scores, and Buss-Perry score and its subscales; IBDQ-E: IBDQ emotional function; IBDQ-SF: IBDQ social function; IBDQ-B: IBDQ bowel
function; IBDQ-SS: IBDQ systemic symptom.
in active group while platelet count was similar between
these groups. Table 2 described demographics and clinical
characteristics of all enrolled subjects.
The mean duration of CD was 2.90 and 4.36 years
for each group. The majority of enrolled patients in both
groups had never received operation or less than 1 oper-
ation. 5-aminosalicylic acid (5-ASA), that mainly includes
sulfasalazine and mesalazine, was prescribed to the majority
of patients in both groups. TWP (Tripterygium wilfordii
polyglycoside) is a traditional Chinese medicine which has
been confirmed to be effective in the management of CD
[22, 23] and therefore becomes a choice of medication
prescriptions in our institute.
Table 3 demonstrated all psychological scores and IBDQ
score and its subscales in both groups. Patientswith activeCD
displayed a significant higher level of neuroticism, anxiety,
depression, physical aggression, and hostility, paralleled to a
significant decrease in HRQoL when compared to patients in
quiescent CD group (Table 3). Meanwhile, there was not any
statistical difference between groups in social desirability and
anger (Table 3). Interestingly, verbal aggression seems to be
more apparent in patients with quiescent CD (Table 3).
We further examined the correlation between various
psychological factors and IBDQ together with its subscales
in separate analyses of active CD (Table 4) and quiescent CD
(Table 5) groups.
In the former group, neuroticism, anxiety, and depression
were negatively correlated with IBDQ and its emotional
function, bowel function, and systemic symptom subscales.
Simultaneously, BPA was correlated with IBDQ and its emo-
tional subscale, whilst physical aggressionwas correlatedwith
IBDQ bowel function; anger and hostility were confirmed
to correlate with IBDQ emotional subscale. However, social
desirability did not correlate with any HRQoL parameters,
while IBDQ social function did not correlate with any of the
psychological variables (Table 4).
In the latter group, neuroticism, anxiety, and depression
were significantly correlated with IBDQ and its all four
subscales. Moreover, hostility was found to correlate with
IBDQ and its emotional and social function subscales. There
was not any other correlations in these patients (Table 5).
We subsequently employed multiple linear regression
analysis to investigate to what extent that psychological
factors could affect IBDQ and its each subscale. Psychological
factors that displayed a statistical correlation with IBDQ
or any subscale in previous correlation analysis were intro-
duced as independent parameters into this regression model.
Table 6 illustrated the results of regression analysis.
In quiescent CD group, a higher level of neuroticism
leads to lower scores of IBDQ, IBDQ emotional function, and
IBDQ bowel function. Meanwhile, a higher level of anxiety
leads to a lower score of IBDQ systemic symptom (Table 6).
In active CD group, neuroticism was similarly confirmed
as a remarkable factor to negatively affect IBDQ, IBDQ
social function, IBDQ bowel function, and IBDQ systemic
symptom. Moreover, IBDQ emotional function in this group
was found to simultaneously interact with both neuroticism
and anxiety. All interactions in this regression analysis were
negative (Table 6).
4. Discussions
To the best of our knowledge, this is the first report investi-
gating correlation between psychological factors andHRQoL
in Chinese patients with Crohn’s disease. Similar studies
have been performed in Europe and North America. Con-
sidering the heterogeneous characteristics of Crohn’s disease
in different ethnic groups reported before, we believe that
our description of psychological traits and their correlation
with HRQoL in Chinese patients would be beneficial for our
colleagues and would contribute to a better understanding
of etiology and tailoring of management in Chinese patients
with Crohn’s disease.
In current study, we discovered that disease activity could
exert significant influence on HRQoL in the presence of
psychological factors. This was in accordance with previous
studies [24]. Vidal and his colleagues [25] confirmed disease
activity as one of strongest predictors of HRQoL impairment.
Haapamaki [26] discovered disease activity as a significant
factor related to HRQoL impairment. Other studies also
reported an adverse effect of disease activity on HRQoL in
CD patients [27].
After dividing enrolled patients into two independent
groups, we discovered that active CD patients were exposed
to significant higher risks of neuroticism, anxiety, depression,
physical aggression, and hostility, together with a significant
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Table 2: Demographics and clinical characteristics in patients with Crohn’s disease.
Quiescent CD (CDAI∗ ≤ 150 points) Active CD (CDAI > 150 points) P
Number of patients 40 40 —
Male (%) 30 (75.0) 31 (77.5) ns
Age (years) 29.2 ± 10.1 35.2 ± 11.4 0.015
Education (years) 13.9 ± 2.92 12.0 ± 3.55 ns
Smoking history ns
Never 27 24
Past smoker 12 11
Current smoker 1 5
Duration of disease (years) 2.90 ± 2.99 4.36 ± 4.23 ns
Times of previous gastrointestinal operations ns
0 20 17
1 13 14
2 6 3
≥3 1 6
Disease location ns
L1 (ileal) 18 18
L2 (colonic) 8 10
L3 (ileocolonic) 14 12
+L4 (upper gastrointestinal) 2 2
Disease behavior ns
B1 (inflammatory) 10 10
B2 (stricturing) 24 23
B3 (penetrating) 6 7
+P (perianal) 18 17
Medications& ns
None 5 0
5-ASA# 22 26
Azathioprine 6 6
TWP% 4 6
Enteral nutrition 18 17
CDAI score 91.8 ± 32.3 247.8 ± 80.2 <0.001
C-reactive protein (mg/L) 17.5 ± 5.32 61.01 ± 12.99 <0.001
Erythrocyte sedimentation rate (mm/hour) 22.4 ± 4.40 37.34 ± 5.29 0.022
Platelet count (×109/L) 202 ± 9.88 289 ± 17.5 ns
∗Crohn’s disease activity score; &summay bemore than 100% as one patientmay be prescribedwith severalmedications; #5-aminosalicylic acidmainly includes
sulfasalazine and mesalazine; %Tripterygium wilfordii polyglycoside; ns: not significant.
decrease in HRQoL compared to patients in quiescent CD. In
correlation analysis, we confirmed that psychological factors,
particularly neuroticism, anxiety, and depression, are related
to IBDQ and its subscales in both active and quiescent
groups.
Neuroticism was demonstrated as a significant variable
that leads to declined scores of IBDQ, IBDQ emotional
function, and IBDQ bowel function in quiescent CD group
and IBDQ, IBDQ social function, IBDQ bowel function, and
IBDQ systemic symptom in active group. This is in line with
the findings from previous studies of IBD [4, 6] and other
disorders [28–30]. We believe that neuroticism should result
from both genetic factor and somatic conditions and could
contribute to vulnerable reaction with depressive symptoms
to stressful life events in these patients [4, 31], which may be
helpful to explain the correlation between neuroticism and
IBDQ emotional function [32].
Several previous studies have investigated the association
between neuroticism and IBDQand its subscales [4, 33].They
consistently confirmed the remarkable role of neuroticism
in the influence of HRQoL on IBD patients. However, they
perform analyses in mixed IBD samples and not effectively
excluded the potential effect that disease activity exerted on
HRQoL. In our study, we divided patients into quiescent and
active CD groups and analyzed them separately to reduce
the interactions among disease activity, psychological factors,
and HRQoL in these patients. In fact, our results confirmed
the distinct variance of psychological scores between active
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Table 3: Psychological variables and HRQoL in patients with Crohn’s disease.
Quiescent CD (CDAI∗ ≤ 150 points) Active CD (CDAI > 150 points) P
Neuroticism score 8.08 ± 5.02 11.0 ± 5.83 0.019
Lie (social conformity/desirability) score 13.5 ± 2.73 12.7 ± 3.06 ns
Hospital anxiety score 5.20 ± 2.91 7.30 ± 3.14 0.003
Hospital depression score 5.03 ± 3.17 6.98 ± 3.08 0.007
Buss-Perry score 69.7 ± 14.0 79.1 ± 16.9 0.008
PA (physical aggression) score 19.5 ± 4.79 21.9 ± 5.79 0.049
VA (verbal aggression) score 19.5 ± 5.25 15.6 ± 3.93 0.011
A (anger) score 13.4 ± 3.64 18.7 ± 5.21 ns
H (hostility) score 17.3 ± 6.54 22.9 ± 5.78 0.007
IBDQ& 181.4 ± 22.3 146.0 ± 31.9 <0.001
Emotional function score 69.7 ± 9.79 57.5 ± 12.8 <0.001
Social function score 23.0 ± 7.01 18.6 ± 7.05 0.006
Bowel function score 60.5 ± 6.68 49.9 ± 9.53 <0.001
Systemic symptom score 28.2 ± 4.68 20.0 ± 5.73 <0.001
∗Crohn’s disease activity score; &Inflammatory Bowel Disease Questionnaire; ns: Not significant.
Table 4: Spearman correlation analysis (P value) between different psychological variables and Inflammatory Bowel Disease Questionnaire
and its subscales in patients with quiescent Crohn’s disease (CDAI ≤ 150 points).
Quiescent CD (CDAI ≤ 150 points)
IBDQ IBDQ-E IBDQ-SF IBDQ-B IBDQ-SS
Neuroticism −0.617∗∗∗ −0.768∗∗∗ −0.116 −0.389∗ −0.476∗∗
Lie (social conformity/desirability) 0.134 0.149 0.038 0.063 0.128
Hospital anxiety −0.421∗∗ −0.562∗∗∗ 0.157 −0.392∗ −0.522∗∗∗
Hospital depression −0.469∗∗ −0.537∗∗∗ 0.012 −0.428∗∗ −0.464∗∗
Buss-Perry score −0.330∗ −0.481∗∗ 0.056 −0.309 −0.261
PA (physical aggression) −0.196 −0.208 0.077 −0.362∗ −0.137
VA (verbal aggression) −0.142 −0.135 −0.051 −0.124 −0.215
A (anger) −0.249 −0.405∗∗ 0.078 −0.231 −0.168
H (hostility) −0.266 −0.465∗∗ 0.059 −0.166 −0.208
IBDQ-E: IBDQ emotional function; IBDQ-SF: IBDQ social function; IBDQ-B: IBDQ bowel function; IBDQ-SS: IBDQ systemic symptom. ∗P < 0.05; ∗∗P <
0.01; ∗∗∗P < 0.001. The bold data indicates a statistical significance in the Spearman correlation analysis.
Table 5: Spearman correlation analysis (P value) between different psychological variables and Inflammatory Bowel Disease Questionnaire
and its subscales in patients with active Crohn’s disease (CDAI > 150 points).
Active CD (CDAI > 150 points)
IBDQ IBDQ-E IBDQ-SF IBDQ-B IBDQ-SS
Neuroticism −0.690∗∗∗ −0.745∗∗∗ −0.651∗∗∗ −0.578∗∗∗ −0.452∗∗
Lie (social conformity/desirability) 0.198 0.240 0.144 0.193 0.222
Hospital anxiety −0.572∗∗∗ −0.669∗∗∗ −0.543∗∗∗ −0.370∗ −0.394∗
Hospital depression −0.463∗∗ −0.560∗∗∗ −0.399∗ −0.363∗ −0.330∗
Buss-Perry score −0.251 −0.238 −0.208 −0.163 −0.125
PA (physical aggression) 0.002 −0.034 −0.025 0.002 −0.024
VA (verbal aggression) −0.080 −0.034 −0.076 −0.111 0.087
A (anger) −0.289 −0.272 −0.162 −0.281 −0.234
H (hostility) −0.434∗∗ −0.467∗∗ −0.388∗ −0.226 −0.292
IBDQ-E: IBDQ emotional function; IBDQ-SF: IBDQ social function; IBDQ-B: IBDQ bowel function; IBDQ-SS: IBDQ systemic symptom. ∗P < 0.05; ∗∗P <
0.01; ∗∗∗P < 0.001. The bold data indicates a statistical significance in the Spearman correlation analysis.
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Table 6: Multiple linear regression analysis between different psychological variables and Inflammatory Bowel Disease Questionnaire and
its subscales in patients with Crohn’s disease.
Quiescent CD (CDAI ≤ 150 points) Active CD (CDAI > 150 points)
Significant
variables
Adjusted
𝑅 square 𝐵 95% CI P value
Significant
variables
Adjusted
𝑅 square 𝐵 95% CI P value
IBDQ Neuroticism 0.363 −2.73 −1.59∼−3.88 <0.001 Neuroticism 0.496 −3.90 −2.64∼−5.16 <0.001
IBDQ-E Neuroticism 0.548 −1.46 −1.03∼−1.88 <0.001 Neuroticism 0.560 −1.10 −0.53∼−1.67 <0.001
Anxiety 0.639 −1.60 −0.54∼−2.65 0.004
IBDQ-SF Neuroticism 0.430 −0.81 −0.51∼−1.10 <0.001
IBDQ-B Neuroticism 0.191 −0.61 −0.22∼−1.00 0.003 Neuroticism 0.336 −0.97 −0.54∼−1.40 <0.001
IBDQ-SS Anxiety 0.290 −0.89 −0.45∼−1.33 <0.001 Neuroticism 0.194 −0.46 −0.17∼−0.74 0.003
IBDQ-E: IBDQ emotional function; IBDQ-SF: IBDQ social function; IBDQ-B: IBDQ bowel function; IBDQ-SS: IBDQ systemic symptom.
and quiescent CD groups (Table 2), making it reasonable
to perform separate analyses which could decrease the bias
brought by mixed samples of patients with various disease
activities.
Our study found anxiety to be a significant factor that
leads to declined scores of IBDQ systemic symptom in quies-
cent CD and IBDQ emotional function (together with neu-
roticism) in active CD patients. Prior studies demonstrated
some controversies regarding the role that anxiety plays in
IBD patients. While some studies reported a prevalence of
anxiety as high as 29–35% in remission and 80% in relapse
[34], others found no evidence of any correlation between
anxiety and CD [35]. A recent study in Korea reported an
incidence of 27.4% in IBD patients, accompanied with a
significant lower quality of life in these patients compared
with healthy controls [36]. We agree with the authors that
anxiety could originate from various concerns and worries
about incurability and uncertain course and prognosis in
Crohn’s disease, as well as fear of surgery or development of
cancer [24, 37].
Our results suggested that in both quiescent and active
CD patients, an increased level of neuroticism and anxiety
might reduce the total IBDQ and some other subscales at a
magnitude that might be of clinical significance. Therefore,
psychological factors, especially neuroticism and anxiety,
should be taken in account when using IBDQ to measure
clinical outcome of interventions in patients with CD.
We confirmed in current study that psychological dis-
tress, concerns, and illnesses could lead to decreased HRQoL
and should draw attention of professional staff. However, the
majority of current strategies for CD did not pay attention
to psychological conditions or concerns in CD patients [24].
Instead, some of their side effects were associated with men-
tal or mood changes, depressions, and other psychological
distresses. Therefore, it could be beneficial if integrating con-
ventional medical therapy with psychological interventions
improves HRQoL in patients with CD.
We are aware of the limitations in this study. First, a
potential risk of selection bias might exist because of the
limited sample size from a single center, which may not
completely reflect the comprehensive relationship between
psychological factors and HRQoL.
Second, this study lacks follow-up prospective data after
receiving psychological interventions in all enrolled patients,
and thus we were deprived of the ability of evaluating efficacy
of psychological treatments in CD patients. However, Boye
and his colleagues [38] in their INSPIRE study declared that
psychotherapy could improve quality of life in UC but not in
CD.Therefore, role of psychotherapy needs to be determined
by further studies.
Third, a disease-specific HRQoL questionnaire (IBDQ)
was adopted in current study, but not a generic questionnaire,
such as SF-36. McColl [39] recommended that generic and
disease-specificmeasures of quality of life are complementary
and thus should be used in parallel in IBD. We agree with
McColl’s suggestion, but we tried to reduce the total time that
all questionnaires take in each participant, therefore assisting
them to answer all questions truthfully and accurately in this
self-reporting investigation.
In conclusion, psychological factors, especially neuroti-
cism and anxiety, can significantly affect HRQoL in patients
with both active and quiescent CD.Therefore, more attention
toward psychological status in Crohn’s patients is required
in current and future management. Furthermore, continued
large studies are expected to enhance our capacity to design
interventions to improve HRQoL and maximize health out-
comes in the management of Crohn’s disease in the future.
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